Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + HDFL in Advanced Gastric Cancer
NCT00270543Phase 2Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in gastric cancer (GC), sponsored by Far Eastern Memorial Hospital. Primary endpoint: Objective Tumor Response Rate. Status: unknown.
02
Drugs
docetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00270543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270543.